The science behind
every Origin Peptide vial.
Origin Peptide isn't a brand — it's a laboratory. Below is the exact methodology by which every compound goes from raw amino acids to a public, ISO 17025-verified vial in your cold-chain envelope.
Batches released
147
Avg HPLC purity
99.4%
Avg purity variance
0.31%
Lab → ledger
<24h
From amino acid
to peer-reviewable vial.
Each stage is documented, timestamped and recoverable. There is no black box.
Solid-phase synthesis
Fmoc/tBu strategy, automated Liberty Blue synthesizers, USP <797> cleanroom conditions. Reagents traced down to the GMP-grade resin lot.
Cleavage & purification
TFA cleavage with optimized scavengers, semi-preparative reverse-phase HPLC purification on C18 columns to a single peak >99%.
Internal QA
In-house HPLC + ESI-MS confirmation, water-content via Karl Fischer, residual solvents by GC-MS, endotoxin LAL on every lot.
Independent ISO 17025
Janoshik Analytical (CZ) and Auburn Labs (US) reproduce HPLC + MS analysis blind. Batch is rejected if results deviate by >0.5%.
Public ledger release
COFA published on the Origin Peptide open ledger, tied to the vial barcode, queryable from any product page within 24h of release.
Recent certificates
of analysis.
Every batch released by Origin Peptide is accompanied by an independent COA. The most recent ones, live.
Engineered with the world's most rigorous laboratories.
Janoshik Analytical (Czech Republic) and Auburn Labs (United States) re-verify every Origin Peptide batch. Both are ISO 17025-accredited and serve top-tier pharmaceutical research clients.
ISO 17025 partner
Janoshik Analytical
Independent third-party HPLC + MS verification. Blind testing protocol.
View accreditationISO 17025 partner
Auburn Labs
Independent third-party HPLC + MS verification. Blind testing protocol.
View accreditation